Brief: Adaptimmune Receives U.S. FDA Accelerated Approval Of Tecelra

Adaptimmune Therapeutics

02/08/2024 01:21

Aug 1 (Reuters) - Adaptimmune Therapeutics PLC  ADAP.O :
    * ADAPTIMMUNE RECEIVES U.S. FDA ACCELERATED APPROVAL OF
TECELRA®
(AFAMITRESGENE AUTOLEUCEL), THE FIRST APPROVED ENGINEERED CELL
THERAPY FOR A SOLID TUMOR
    * ADAPTIMMUNE THERAPEUTICS PLC - APPROVED FOR ADVANCED
MAGE-A4+SYNOVIAL SARCOMA IN ADULTS

Source text for Eikon:  ID:nBw56v1Cza 
Further company coverage:  ADAP.O 

 ((Reuters.Briefs@thomsonreuters.com;))